Literature DB >> 16362632

Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.

D Peleg-Raibstein1, E Sydekum, H Russig, J Feldon.   

Abstract

The present study represents a continuous effort to develop an animal model of schizophrenia based on the "endogenous dopamine sensitization" hypothesis. To achieve this goal, withdrawal from an escalating amphetamine (AMPH) regime administration [three injections per day over a period of 4 days and increasing doses from 1 to 10 mg/kg of AMPH or an equivalent volume of saline (SAL)] was employed. Animals exposed to this treatment were evaluated on their performance in attentional (Latent inhibition, LI) and sensorimotor gating (Prepulse inhibition, PPI) tasks in a drug free state and tested for locomotor sensitization following a low dose of AMPH challenge administration.LI using active avoidance, tested on withdrawal day 4, was unaffected. PPI of the acoustic startle response, measured on withdrawal days 6 and 70, was disrupted. On the 76th day of withdrawal, a low challenge dose of AMPH (1 mg/kg) led to a clear locomotor sensitization effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362632     DOI: 10.1007/s00702-005-0390-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  60 in total

1.  Presidential Address, 1974. The more or less startling effects of weak prestimulation.

Authors:  F K Graham
Journal:  Psychophysiology       Date:  1975-05       Impact factor: 4.016

2.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

3.  Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.

Authors:  Holger Russig; Carol A Murphy; Joram Feldon
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

4.  Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.

Authors:  D Lin; G F Koob; A Markou
Journal:  Psychopharmacology (Berl)       Date:  1999-08       Impact factor: 4.530

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

6.  Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA axis to a subsequent stressor.

Authors:  Alasdair M Barr; Candace E Hofmann; Joanne Weinberg; Anthony G Phillips
Journal:  Neuropsychopharmacology       Date:  2002-03       Impact factor: 7.853

7.  Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration.

Authors:  Carol A Murphy; Holger Russig; Marie-Astrid Pezze; Boris Ferger; Joram Feldon
Journal:  Neuropharmacology       Date:  2003-06       Impact factor: 5.250

8.  Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

Authors:  N S Gray; L S Pilowsky; J A Gray; R W Kerwin
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

Review 9.  Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research.

Authors:  Veena Kumari; Tonmoy Sharma
Journal:  Psychopharmacology (Berl)       Date:  2002-06-05       Impact factor: 4.530

10.  The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice.

Authors:  Benjamin K Yee; D L Tilly Chang; Joram Feldon
Journal:  Neuropsychopharmacology       Date:  2004-10       Impact factor: 7.853

View more
  9 in total

Review 1.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Baseline prepulse inhibition expression predicts the propensity of developing sensitization to the motor stimulant effects of amphetamine in C57BL/6 mice.

Authors:  Daria Peleg-Raibstein; Jonas Hauser; Luis H Llano Lopez; Joram Feldon; Pascual A Gargiulo; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2012-08-17       Impact factor: 4.530

3.  Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways.

Authors:  Saba Feizipour; Sarvenaz Sobhani; Shafagh Mehrafza; Mina Gholami; Majid Motaghinejad; Manijeh Motevalian; Sepideh Safari; Reza Davoudizadeh
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

4.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

Review 5.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

6.  Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration.

Authors:  T Featherby; M van den Buuse; D I Lubman; A J Lawrence
Journal:  Br J Pharmacol       Date:  2008-05       Impact factor: 8.739

7.  The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?

Authors:  Daria Peleg-Raibstein; Benjamin K Yee; Joram Feldon; Jonas Hauser
Journal:  Psychopharmacology (Berl)       Date:  2009-03-27       Impact factor: 4.530

8.  Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.

Authors:  Justine Renard; Michael Loureiro; Laura G Rosen; Jordan Zunder; Cleusa de Oliveira; Susanne Schmid; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

9.  Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact.

Authors:  Daria Peleg-Raibstein; Esther Sydekum; Holger Russig; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.